Anupriya Adhikari
-
- Bioactive Compounds and Antitumor Agents 2
-
- Radiopharmaceutical Chemistry and Applications 5
-
- Peptidase Inhibition and Analysis 2
-
- Alzheimer's disease research and treatments 3
-
- Cancer therapeutics and mechanisms 3
- DNA and Nucleic Acid Chemistry 3
-
- Cancer, Hypoxia, and Metabolism 2
-
- Amino Acid Enzymes and Metabolism 1
- Co-authors
- Manish AdhikariNeha KaushikNagendra Kumar KaushikEun Ha ChoiAbdulaziz A. Al‐KhedhairyAnjani K. TiwariAnupama DattaKrishna Chuttani
- Journals
- Pharmaceutical Research (1 paper)Oncotarget (1 paper)Bioorganic & Medicinal Chemistry (2 papers)
- Partner nations
- IndiaSouth KoreaUnited States
In The Last Decade
Anupriya Adhikari
19 papers receiving 318 citations
Peers
Comparison fields: 5 of 84
- Toxicology 12
- Plant Science 118
- Radiology, Nuclear Medicine and Imaging 51
- Oncology 54
- Cell Biology 26
Countries citing papers authored by Anupriya Adhikari
This map shows the geographic impact of Anupriya Adhikari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anupriya Adhikari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anupriya Adhikari more than expected).
Fields of papers citing papers by Anupriya Adhikari
This network shows the impact of papers produced by Anupriya Adhikari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anupriya Adhikari. The network helps show where Anupriya Adhikari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anupriya Adhikari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 28 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 13 | |
| 13 | 2020 | 19 | |
| 14 | 2019 | 5 | |
| 15 | 2017 | 26 | |
| 16 | 2017 | 141 | |
| 17 | DNA TARGETED ANTHRAQUINONE DERIVATIVES: AN IMPORTANT ANTICANCER AGENTS | 2016 | 14 |
| 18 | PRELIMINARY EVALUATION OF AN ANTHRAQUINONE CONJUGATED DOTA DERIVATIVE AS SPECT AGENT | 2015 | 2 |
| 19 | 2014 | 34 | |
| 20 | 2014 | 5 |
About Anupriya Adhikari
Anupriya Adhikari is a scholar working on Toxicology, Biological Psychiatry and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 324 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (5 papers), Alzheimer's disease research and treatments (3 papers), Cancer therapeutics and mechanisms (3 papers), DNA and Nucleic Acid Chemistry (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Peptidase Inhibition and Analysis (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). The work is most often cited by research in Toxicology (12 citations), Plant Science (118 citations) and Radiology, Nuclear Medicine and Imaging (51 citations). Anupriya Adhikari has collaborated with scholars based in India, South Korea and United States. Frequent co-authors include Manish Adhikari, Neha Kaushik, Nagendra Kumar Kaushik, Eun Ha Choi, Abdulaziz A. Al‐Khedhairy, Anjani K. Tiwari, Anupama Datta, Krishna Chuttani, Kanchan Chauhan and Ajai K. Singh. Their work appears in journals such as Pharmaceutical Research, Oncotarget and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.